dr. jacobson on the benefit of axi-cel in relapsed/refractory follicular lymphoma
Published 4 years ago • 127 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:22
dr. jacobson on the safety profile of axi-cel in relapsed/refractory indolent lymphoma
-
1:49
dr. jacobson on design of zuma-5 trial in r/r indolent non-hodgkin lymphoma
-
1:18
dr. burke on treatment options in relapsed/refractory follicular lymphoma
-
4:51
zuma-5: axi-cel for r/r non-hodgkin lymphoma
-
1:55
car-t research from dana-farber in follicular lymphoma and marginal zone lymphoma
-
2:43
long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
-
10:21
advances in car-t therapy for lymphoma
-
2:03
dr. abramson on safety and efficacy of liso-cel in relapsed/refractory large b-cell lymphoma
-
1:15
primary overall survival analysis of the zuma-7 trial
-
1:42
caron jacobson, md, on treatment and research in lymphomas
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
6:45
anticipation of zuma-7 results
-
2:48
cancer research: fda approves car t-cell therapy for indolent follicular lymphoma
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
1:51
refract: standard chemoimmunotherapy versus novel agents in r/r follicular lymphoma
-
3:21
comparing the efficacy of tisa-cel and axi-cel in patients with r/r fl
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
1:26:18
new models for nhl care: innovative therapy in fl and dlbcl
-
1:30
dr. cheson discusses the diagnosis of follicular lymphoma